1
|
Yamashita Y, Komohara Y, Takahashi M, et
al: Abdominal helical CT: Evaluation of optimal doses of
intravenous contrast material - a prospective randomized study.
Radiology. 216:718–723. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Awai K, Takada K, Onishi H and Hori S:
Aortic and hepatic enhancement and tumor-to-liver contrast:
Analysis of the effect of different concentrations of contrast
material at multi-detector row helical CT. Radiology. 224:757–763.
2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Foley WD, Hoffmann RG, Quiroz FA, Kahn CE
Jr and Perret RS: Hepatic helical CT: Contrast material injection
protocol. Radiology. 192:367–371. 1994. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tublin ME, Tessler FN, Cheng SL, Peters TL
and McGovern PC: Effect of injection rate of contrast medium on
pancreatic and hepatic helical CT. Radiology. 210:97–101. 1999.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Goshima S, Kanematsu M, Kondo H, et al:
MDCT of the liver and hypervascular hepatocellular carcinomas:
Optimizing scan delays for bolus-tracking techniques of hepatic
arterial and portal venous phases. AJR Am J Roentgenol.
187:W25–W32. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kondo H, Kanematsu M, Goshima S, et al:
MDCT of the pancreas: Optimizing scanning delay with a
bolus-tracking technique for pancreatic, peripancreatic vascular,
and hepatic contrast enhancement. AJR Am J Roentgenol. 188:751–756.
2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Heiken JP, Brink JA, McClennan BL, Sagel
SS, Crowe TM and Gaines MV: Dynamic incremental CT: Effect of
volume and concentration of contrast material and patient weight on
hepatic enhancement. Radiology. 195:353–357. 1995. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bae KT, Heiken JP and Brink JA: Aortic and
hepatic contrast medium enhancement at CT. Part II. Effect of
reduced cardiac output in a porcine model. Radiology. 207:657–662.
1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Davies B and Morris T: Physiological
parameters in laboratory animals and humans. Pharm Res.
10:1093–1095. 1993. View Article : Google Scholar : PubMed/NCBI
|
10
|
Morgan DJ and Bray KM: Lean body mass as a
predictor of drug dosage. Implications for drug therapy. Clin
Pharmacokinet. 26:292–307. 1994. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ho LM, Nelson RC and Delong DM:
Determining contrast medium dose and rate on basis of lean body
weight: Does this strategy improve patient-to-patient uniformity of
hepatic enhancement during multi-detector row CT. Radiology.
243:431–437. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yoshizumi T, Nakamura T, Yamane M, et al:
Abdominal fat: Standardized technique for measurement at CT.
Radiology. 211:283–286. 1999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kondo H, Kanematsu M, Goshima S, et al:
Abdominal multidetector CT in patients with varying body fat
percentages: Estimation of optimal contrast material dose.
Radiology. 249:872–877. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Itoh S, Ikeda M, Satake H, Ota T and
Ishigaki T: The effect of patient age on contrast enhancement
during CT of the pancreatobiliary region. AJR Am J Roentgenol.
187:505–510. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lasser EC, Lyon SG and Berry CC: Reports
on contrast media reactions: Analysis of data from reports to the
U.S. Food and Drug Administration. Radiology. 203:605–610. 1997.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Tublin ME, Murphy ME and Tessler FN:
Current concepts in contrast media-induced nephropathy. AJR Am J
Roentgenol. 171:933–939. 1998. View Article : Google Scholar : PubMed/NCBI
|